{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T22:36:39Z","timestamp":1761172599238,"version":"build-2065373602"},"reference-count":17,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal de Mycologie M\u00e9dicale"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.mycmed.2017.07.009","type":"journal-article","created":{"date-parts":[[2018,2,2]],"date-time":"2018-02-02T20:22:55Z","timestamp":1517602975000},"page":"201-205","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Necessity to identify the causative agent for appropriate treatment in fungal corneal ulcer: an in vitro study"],"prefix":"10.1016","volume":"28","author":[{"given":"M.K.","family":"Gupta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Tilak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mycmed.2017.07.009_bib0090","first-page":"573","article-title":"In vitro efficacy and fungicidal activity of voriconazole against Aspergillus and Fusarium species","volume":"17","author":"Clancy","year":"1998","journal-title":"Eur J Clin Microbiol Infect Dis"},{"year":"2008","series-title":"Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard CLSI document M38-A2","author":"Clinical and Laboratory Standards Institute","key":"10.1016\/j.mycmed.2017.07.009_bib0095"},{"key":"10.1016\/j.mycmed.2017.07.009_bib0100","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/jac\/42.4.531","article-title":"Comparison of the in-vitro activity of voriconazole (UK-109,496), itraconazole and amphotericin B against clinical isolates of Aspergillus fumigatus","volume":"42","author":"Cuenca-Estrella","year":"1998","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.mycmed.2017.07.009_bib0105","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/0002-9394(86)90953-0","article-title":"Miconazole and ketoconazole as a satisfactory first line treatment for keratomycosis","volume":"101","author":"Fitzsimons","year":"1986","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.mycmed.2017.07.009_bib0110","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.1128\/JCM.37.12.4170-4173.1999","article-title":"Mycotic keratitis due to Curvularia senegalensis and invitro antifungal susceptibilities of Curvularia spp","volume":"37","author":"Guarro","year":"1999","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.mycmed.2017.07.009_bib0115","doi-asserted-by":"crossref","first-page":"462","DOI":"10.4103\/0255-0857.158609","article-title":"Fungal keratitis in north India; spectrum and diagnosis by calcofluor white stain","volume":"33","author":"Gupta","year":"2015","journal-title":"Indian J Med Microbiol"},{"key":"10.1016\/j.mycmed.2017.07.009_bib0120","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1128\/JCM.00610-08","article-title":"In vitro natamycin susceptibility of ocular isolates of Fusarium and Aspergillus species: comparison of commercially formulated natamycin eye drops to pharmaceutical-grade powder","volume":"46","author":"Lalitha","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.mycmed.2017.07.009_bib0125","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.ajo.2008.06.008","article-title":"In vitro evaluation of combination antifungal activity against Fusarium species isolated from ocular tissues of keratomycosis patients","volume":"146","author":"Li","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.mycmed.2017.07.009_bib0130","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1128\/JCM.41.5.2261-2264.2003","article-title":"Keratitis caused by Scedosporium apiospermum successfully treated with a cornea transplant and voriconazole","volume":"41","author":"Nulens","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.mycmed.2017.07.009_bib0135","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1128\/AAC.48.5.1912-1915.2004","article-title":"In vitro activity of anidulafungin against selected clinically important mould isolates","volume":"48","author":"Odabasi","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2017.07.009_bib0140","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1128\/JCM.00793-10","article-title":"Spectrum of clinically relevant Acremonium species in the United States","volume":"49","author":"Perdomo","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.mycmed.2017.07.009_bib0145","doi-asserted-by":"crossref","first-page":"512","DOI":"10.4103\/0301-4738.86328","article-title":"Natamycin in the treatment of keratomycosis: correlation of treatment outcome and in vitro susceptibility of fungal isolates","volume":"59","author":"Pradhan","year":"2011","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.mycmed.2017.07.009_bib0150","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/00003226-200301000-00008","article-title":"Activity of voriconazole against corneal isolates of Scedosporium apiospermum","volume":"22","author":"Shah","year":"2003","journal-title":"Cornea"},{"key":"10.1016\/j.mycmed.2017.07.009_bib0155","doi-asserted-by":"crossref","first-page":"6393","DOI":"10.1074\/jbc.M707821200","article-title":"Natamycin blocks fungal growth by binding specifically to ergosterol without permeabilizing the membrane","volume":"283","author":"Te Welscher","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.mycmed.2017.07.009_bib0160","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1128\/CMR.16.4.730-797.2003","article-title":"Current perspectives on ophthalmic mycoses","volume":"16","author":"Thomas","year":"2003","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.mycmed.2017.07.009_bib0165","doi-asserted-by":"crossref","first-page":"713687","DOI":"10.1155\/2012\/713687","article-title":"Antifungal resistance and new strategies to control fungal infections","volume":"2012","author":"Vandeputte","year":"2012","journal-title":"Int J Microbiol"},{"key":"10.1016\/j.mycmed.2017.07.009_bib0170","first-page":"214","article-title":"Corneal blindness: a global perspective","volume":"79","author":"Whitcher","year":"2001","journal-title":"Bull World Health Organ"}],"container-title":["Journal de Mycologie M\u00e9dicale"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1156523317300926?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1156523317300926?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T05:19:18Z","timestamp":1761110358000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1156523317300926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S1156523317300926"],"URL":"https:\/\/doi.org\/10.1016\/j.mycmed.2017.07.009","relation":{},"ISSN":["1156-5233"],"issn-type":[{"type":"print","value":"1156-5233"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Necessity to identify the causative agent for appropriate treatment in fungal corneal ulcer: an in vitro study","name":"articletitle","label":"Article Title"},{"value":"Journal de Mycologie M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mycmed.2017.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}